NESHER PHARMS FDA Approval ANDA 211543

ANDA 211543

NESHER PHARMS

FDA Drug Application

Application #211543

Application Sponsors

ANDA 211543NESHER PHARMS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL325MG;50MG;40MG0BUTALBITAL, ACETAMINOPHEN AND CAFFEINEACETAMINOPHEN; BUTALBITAL; CAFFEINE

FDA Submissions

UNKNOWN; ORIG1AP2020-07-17STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

NESHER PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211543
            [companyName] => NESHER PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","strength":"325MG;50MG;40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/17\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-07-17
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.